CLINICAL_TRIALS
trial_result
· 2025-12-03
Clinical Trial Update: STop and Restart Acalabrutinib In fRail Patients With Previously Untreated Chronic Lymphocytic Leukemia [Phase 2]
Summary
A Phase 2 trial of acalabrutinib for untreated chronic lymphocytic leukemia is ongoing. The study status is currently active but not recruiting.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: French Innovative Leukemia Organisation | Conditions: Untreated Chronic Lymphocytic Leukemia | Phase 2 | Status: ACTIVE_NOT_RECRUITING